The Global Market for Parenteral Nutrition is Forecast to Reach US$8.7 Billion by 2020

Rising Popularity of Home Based Infusion Nutrition Therapy Drives Growth in the Global Parenteral Nutrition Market, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Parenteral Nutrition. The global market for Parenteral Nutrition is forecast to reach US$8.7 billion by 2020, driven by the growing popularity of home health nutrition therapy.

Parenteral nutrition refers to feeding patients through the intravenous route, bypassing the normal route of feeding, specifically in patients with a dysfunctional gastrointestinal tract. Increase in the number of age-related chronic diseases, rising prevalence of Crohn's disease, inflammatory bowel disease, stomach cancer, and ulcerative colitis, and other long-term disability, which mandate the administration of nutritional support, are driving growth in the market. Rising volumes of surgeries worldwide and the ensuing risk of postoperative gastrointestinal tract dysfunction is also expected to spur growth in the market. Infant parenteral nutrition is forecast to open new avenues for growth supported by rising maternal age and a parallel rise in premature births. The growth in the market will also benefit from the development of novel products for home use, given the growing preference for home care among individuals suffering from terminal illnesses such as HIV/AIDS and cancer.

Technology innovations, such as, three-chamber bags and pre-mixed frozen solutions, are having a positive impact on the market. Multi-chamber bags, which include 2- and 3-chamber bags containing all the required nutrients, are becoming the preferred choice for parenteral nutrition, primarily due to the fact that these bags reduce preparation time and also eliminate contamination risks and medication errors generally associated with mixing of single dose solutions. Another trend in the market is the shifting consumer preference for pre-mixed solutions, in order to reduce medication errors and to ensure timely delivery of essential nutrients in emergency scenarios.

As stated by the new market research report on Parenteral Nutrition, the United States represents the largest market worldwide. Aging population, increase in the number of chronic diseases such as cancer, AIDS and GI disorders, and favorable reimbursement coverage, are expected to foster growth in country. Asia-Pacific is forecast to emerge as the fastest growing market with a CAGR of 11% over the analysis period, driven by factors such as, developing healthcare infrastructure, easy access to affordable healthcare services, rising standards of living and a parallel increase in healthcare spending. China is forecast to witness strong growth, given the country’s rapidly aging population, and the government’s focus on developing a viable long-term care system.

Key players covered in the market include Actavis Inc., Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Fresenius KABI AG, Grifols International S.A., Hospira Inc., Otsuka Pharmaceutical Factory Inc., Sichuan Kelun Pharmaceutical Co. Ltd., and Sino-Swed Pharmaceutical Corp. Ltd., among others.

The research report titled “Parenteral Nutrition: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (Australia, China, India, and Rest of Asia-Pacific), Middle East/Africa, and Latin America (Brazil, Mexico, and Rest of Latin America).